Provided by Tiger Fintech (Singapore) Pte. Ltd.

Adaptimmune Therapeutics PLC

0.2397
-0.0053-2.16%
Post-market: 0.24290.0032+1.34%19:53 EDT
Volume:561.60K
Turnover:134.88K
Market Cap:63.53M
PE:-0.82
High:0.2471
Open:0.2400
Low:0.2371
Close:0.2450
Loading ...
Feb 16, 2024

Major Issues Report

Form 8-K - Current report
Feb 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 31, 2024

Major Issues Report

Form 8-K - Current report
Jan 30, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 04, 2024

Major Issues Report

Form 8-K - Current report
Dec 06, 2023

Major Issues Report

Form 8-K - Current report
Dec 01, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 14, 2023

Major Issues Report

Form 8-K - Current report
Nov 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 08, 2023

Major Issues Report

Form 8-K - Current report
Nov 08, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 03, 2023

Major Issues Report

Form 8-K - Current report
Oct 31, 2023

Major Issues Report

Form 8-K - Current report
Aug 31, 2023

Major Issues Report

Form 8-K - Current report
Aug 10, 2023

Major Issues Report

Form 8-K/A - Current report: [Amend]
Aug 09, 2023

Major Issues Report

Form 8-K - Current report
Aug 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 10, 2023

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jun 30, 2023

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments